- Previous Close
2,384.00 - Open
2,350.00 - Bid 2,330.00 x --
- Ask 2,340.00 x --
- Day's Range
2,306.00 - 2,365.00 - 52 Week Range
2,300.00 - 2,879.00 - Volume
88,200 - Avg. Volume
51,806 - Market Cap (intraday)
69.725B - Beta (5Y Monthly) -0.12
- PE Ratio (TTM)
8.47 - EPS (TTM)
275.41 - Earnings Date May 8, 2025 - May 12, 2025
- Forward Dividend & Yield 95.00 (4.07%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
Riken Vitamin Co., Ltd. engages in the food ingredient, food improving agents, health care, consumer and commercial foods, and chemical improving agents, and vitamins businesses in Japan. It offers dressing, such as non-oil dressings; seaweed; and extract / seasoning, soup, soup stock, retort-packed food, salad-related products, seafood / meat extracts, and cut wakame. The company also provides food improving agents, including food emulsifiers, processed oils, natural colorants, and vitamin E for emulsification, anti-staling, foaming, coagulation, anti-sticking, texture improvement, coloring, nutritional enhancement, and antioxidant to food manufacturers; and chemical improving agents for anti-fogging, plasticization, lubrication, anti-static, thickening, cleaning, mold release, dispersion, and antioxidant. In addition, it offers health care products, including crocetin, a natural yellow colorant; mekabu fucoidan, a viscous ingredient; carotenoids; vitamin; and improving agents, such as pork extract. The company was formerly known as Riken Vitamin Oil Co., Ltd. and changed its name to Riken Vitamin Co., Ltd. in 1980. Riken Vitamin Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan.
www.rikenvitamin.jp1,857
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 4526.T
View MorePerformance Overview: 4526.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4526.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4526.T
View MoreValuation Measures
Market Cap
69.72B
Enterprise Value
61.69B
Trailing P/E
8.48
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.75
Price/Book (mrq)
0.87
Enterprise Value/Revenue
0.65
Enterprise Value/EBITDA
5.30
Financial Highlights
Profitability and Income Statement
Profit Margin
8.93%
Return on Assets (ttm)
4.99%
Return on Equity (ttm)
10.70%
Revenue (ttm)
95.28B
Net Income Avi to Common (ttm)
8.51B
Diluted EPS (ttm)
275.41
Balance Sheet and Cash Flow
Total Cash (mrq)
18.67B
Total Debt/Equity (mrq)
13.27%
Levered Free Cash Flow (ttm)
--